Kainos shares are rising today: would I buy?

The Kainos share price rose sharply on Friday after the IT services company upgraded its profit guidance and said it was continuing to win new work.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Shares in IT services firm Kainos Group (LSE: KNOS) are up by 18% as I write on Friday morning. The Kainos share price has now risen by 57% over the last year and by more than 500% over the last five years.

Today’s gains come after the firm said that it now expects profits for the current year to be ahead of market forecasts.

Strong trading since November

Kainos says that trading has been strong since the company’s last update in November. Both of the company’s divisions are said to be performing well.

The group’s Digital Services business is working on a number of “substantial, long-term” UK government projects relating to digital transformation. The firm is also supporting the NHS as it responds to Covid-19.

Revenue from digital services rose by 16% to £71m during the six months to 30 September. This business now generates about 65% of the group’s revenue, making it the larger of its two divisions.

However, growth appears to be much stronger in the smaller Workday division, which provides consultancy and support for companies using Workday software — a finance, HR, and business planning system.

In its half-year accounts, Kainos said that revenue from Workday rose by 41% to £36m. This momentum appears to have continued during the second half of the year. Today Kainos said it is continuing to win new consulting contracts for Workday, especially in North America.

Kainos shares: is the price right?

Belfast-based IT group Kainos was founded in 1986. The company is now a FTSE 250 member with a market capitalisation of £1.4bn.

I’d like to have more technology exposure in my shares portfolio. Kainos is one of the companies I’ve been considering to satisfy this goal. One attraction of this business for me is that it has quite high profit margins and appears to generate plenty of surplus cash.

Over the last few years, strong profit growth has supported a rapid increase in the Kainos share price. However, the company warned today that both Covid-19 and Brexit are posing some “ongoing challenges”. The firm’s management still believe that Kainos is “well-positioned for further growth”. But I’m worried that if I buy today, I may end up paying too much for this stock.

My personal approach to investing is that I can accept an uncertain outlook if the shares I buy are cheap enough to reflect this uncertainty. Before today’s news, Kainos shares were trading on about 36 times forecast earnings for 2020/21, with a dividend yield of 1.4%.

In my view, this valuation only looks sustainable if growth remains strong. Before deciding to buy, I need to ask myself what might happen if profit growth slowed. In this case, I think the shares could fall sharply to trade on a lower multiple of earnings.

Although I would like to own Kainos shares some day, my decision after today’s news is that I will continue to watch this business. Hopefully, I’ll be able to add Kainos to my portfolio more cheaply in the future.

Roland Head has no position in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended Workday. The Motley Fool UK has recommended Kainos. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Close-up of British bank notes
Investing Articles

£20,000 for a Stocks and Shares ISA? Here’s how to try and turn it into a monthly passive income of £493

Hundreds of pounds in passive income a month from a £20k Stocks and Shares ISA? Here's how that might work…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

£5,000 put into Nvidia stock last Christmas is already worth this much!

A year ago, Nvidia stock was already riding high -- but it's gained value since. Our writer explores why and…

Read more »

Investing Articles

Are Tesco shares easy money heading into 2026?

The supermarket industry is known for low margins and intense competition. But analysts are bullish on Tesco shares – and…

Read more »

Smiling black woman showing e-ticket on smartphone to white male attendant at airport
Investing Articles

Can this airline stock beat the FTSE 100 again in 2026?

After outperforming the FTSE 100 in 2025, International Consolidated Airlines Group has a promising plan to make its business more…

Read more »

Investing Articles

1 Stocks and Shares ISA mistake that will make me a better investor in 2026

All investors make mistakes. The best ones learn from them. That’s Stephen Wright’s plan to maximise returns from his Stocks…

Read more »

Portrait Of Senior Couple Climbing Hill On Hike Through Countryside In Lake District UK Together
Investing Articles

I asked ChatGPT if £20,000 would work harder in an ISA or SIPP in 2026 and it said…

Investors have two tax-efficient ways to build wealth, either in a Stocks and Shares ISA or SIPP. Harvey Jones asked…

Read more »

Investing Articles

How much would I need invested in an ISA to earn £2,417 a month in passive income?

This writer runs the numbers to see what it takes in an ISA to reach £2,417 a month in passive…

Read more »

Investing Articles

Rolls-Royce shares or Melrose Industries: Which one is better value for 2026?

Rolls-Royce shares surged in 2025, surpassing most expectations. Dr James Fox considers whether it offers better value than peer Melrose.

Read more »